SEC Form 4 · accession 0001437749-15-004008
HYPERION THERAPEUTICS INC · HPTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bruce Frederick Scharschmidt
Officer — SVP & Chief Medical Officer
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001386858
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | S | 24,996 | $29.79 | D | 29,252 | I | By The Bruce Frederick Scharschimdt and Peggy Sue |
| Common StockF2 | Feb 27, 2015 | S | 4,804 | $30.43 | D | 24,448 | I | Crawford Family Trust dated October 9, 2001 |
| Common Stock | holding | — | — | — | 97,471 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27-$30.26. The reporting person undertakes to provide Hyperion Therapeutics, Inc, any security holder of Hyperion Therapeutics, Inc or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2The price reported in column 4 is weighted average price. These shares were sold in multiple transactions ranging from $30.26-$30.59, inclusive.